prep. TLC with CHCl 3 -MeOH (100:5) to give 13 (11.7 mg), 21 (16.5 mg), 22 (12.6 mg), 23 (6.5 mg), 24 (26.9 mg), and 33 (11.8 mg). By similar procedures, compounds 7 (18.5 mg), 14 (16.8 mg), 25 (14.5 mg), 26 (25.6 mg), 27 (23.3 mg), 35 (14.8 mg), 36 (17.5 mg), 37 (25.7 mg), 38 (36.5 mg), 43 (19.6 mg), 47 (27.5 Compounds 16 (13.5 mg), 17 (18.9 mg), 18 (15.2 mg), 50 (80.3 mg), 56 (20.7 mg), and 58 (16.3 mg) were obtained from fraction E2 by similar methods. Fraction E3 was subjected to CC over Sephadex LH-20 eluting with CHCl 3 -MeOH (50:50 and 0:100), followed by purification with prep. TLC with CHCl 3 -MeOH (100:20) to give compounds 1 (30.6 mg), 6 (38.8 mg), 39 (13.5 mg), 41 (13.1 mg), 42 (19.2 mg), and 48 (14.0 mg). Similarly, compounds 51 (54.0 mg), 52 (100.2 mg), 53 (156.4 mg), 54 (61.0 mg), 55 (12.7 mg), and 60 (52.9 mg) were isolated from fraction E4. The purities of these compounds ranged from 90.1% to 96.0% determined by HPLC.
References for known compounds
By comparing their physical and spectroscopic data with published data, the structures of the known 56 compounds were identified as six monoterpenes: uroterpenol (7) Kubo M, Nagai M, Inoue T. Studies on the constituents of Aceraceae plants. IV. carbon-13 nuclear magnetic resonance spectra of acerogenin A, rhododendrol and related compounds, and structure of aceroside IV from Acer nikoense. Chem Pharm Bull 1983; 31: 1917 -1922 List of Figures   Fig. 1S 1 H NMR spectrum of compound 1 in CD 3 OD.
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